Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 5Q686XLG8L

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Killer cell immunoglobulin-like receptor 2DL1 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Multiple Myeloma 2 D009101 ClinicalTrials
Leukemia, Myeloid, Acute 1 D015470 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109498
FDA SRS 5Q686XLG8L